Works matching IS 03065251 AND DT 2020 AND VI 86 AND IP 4
Results: 23
Issue highlights.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 625, doi. 10.1111/bcp.14282
- Publication type:
- Article
A systematic review and combined meta‐analysis of concentration of oral amisulpride.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 668, doi. 10.1111/bcp.14246
- By:
- Publication type:
- Article
Ensuring access to safe, effective, and affordable cannabis‐based medicines.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 630, doi. 10.1111/bcp.14242
- By:
- Publication type:
- Article
How the EMERGE guideline on medication adherence can improve the quality of clinical trials.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 687, doi. 10.1111/bcp.14240
- By:
- Publication type:
- Article
Medication adherence—Key considerations for clinical pharmacologists.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 628, doi. 10.1111/bcp.14228
- By:
- Publication type:
- Article
Legal regulations, ethical guidelines and recent policies to increase transparency of clinical trials.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 679, doi. 10.1111/bcp.14223
- By:
- Publication type:
- Article
Measuring the impact of risk communications: Robust analytical approaches are key.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 635, doi. 10.1111/bcp.14222
- By:
- Publication type:
- Article
Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 646, doi. 10.1111/bcp.14210
- By:
- Publication type:
- Article
The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 637, doi. 10.1111/bcp.14198
- By:
- Publication type:
- Article
First‐in‐human, randomized dose‐escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF‐06480605 in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 812, doi. 10.1111/bcp.14187
- By:
- Publication type:
- Article
Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 801, doi. 10.1111/bcp.14186
- By:
- Publication type:
- Article
Modelling pharmacokinetics and pharmacodynamics of the selective S1P<sub>1</sub> receptor modulator cenerimod in healthy subjects and systemic lupus erythematosus patients.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 791, doi. 10.1111/bcp.14182
- By:
- Publication type:
- Article
Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 779, doi. 10.1111/bcp.14179
- By:
- Publication type:
- Article
Evaluation of the effect of P‐glycoprotein inhibition and induction on talazoparib disposition in patients with advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 771, doi. 10.1111/bcp.14178
- By:
- Publication type:
- Article
Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 763, doi. 10.1111/bcp.14177
- By:
- Publication type:
- Article
Does green tea extract enhance the anti‐inflammatory effects of exercise on fat loss?
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 753, doi. 10.1111/bcp.14176
- By:
- Publication type:
- Article
Acute caffeine intake increases performance in the 15‐s Wingate test during the menstrual cycle.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 745, doi. 10.1111/bcp.14175
- By:
- Publication type:
- Article
Adrenal gland‐released vasostatin‐I is a myocardial depressant factor.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 825, doi. 10.1111/bcp.14173
- By:
- Publication type:
- Article
The ABC taxonomy for medication adherence translated into French and German.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 734, doi. 10.1111/bcp.14172
- By:
- Publication type:
- Article
A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 723, doi. 10.1111/bcp.14166
- By:
- Publication type:
- Article
Serious adverse effects occurring after chemotherapy: A general cancer registry‐based incidence survey.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 711, doi. 10.1111/bcp.14159
- By:
- Publication type:
- Article
Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta‐analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 698, doi. 10.1111/bcp.14104
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 623, doi. 10.1111/bcp.14006
- Publication type:
- Article